PortadaGruposCharlasMásPanorama actual
Buscar en el sitio
Este sitio utiliza cookies para ofrecer nuestros servicios, mejorar el rendimiento, análisis y (si no estás registrado) publicidad. Al usar LibraryThing reconoces que has leído y comprendido nuestros términos de servicio y política de privacidad. El uso del sitio y de los servicios está sujeto a estas políticas y términos.

Resultados de Google Books

Pulse en una miniatura para ir a Google Books.

Cargando...

The $1,000 Genome: The Revolution in DNA Sequencing and the New Era of Personalized Medicine

por Kevin Davies

MiembrosReseñasPopularidadValoración promediaConversaciones
536491,233 (3.21)Ninguno
Science. Nonfiction. Since the conclusion of the Human Genome Project in 2003, scientists have been racing toward a grand goal: offering individuals a decoding of their complete genetic makeup for just $1,000. As Kevin Davies reveals in this exquisitely reported account, the $1,000 genome will be a reality by 2011 and it will usher in a whole new era of personalized, genomic medicine. Capable of presenting much more advanced information than the current crop of cheek-swab services, the $1,000 complete genome raises some extraordinary possibilities. We will be able to learn if we have genes that predispose us to a host of diseases and to take a wide range of preventative measures. Drug companies may be able to create versions of drugs tailored specifically to our individual DNA. But we may also face the psychological burden of learning that we have the gene for an incurable disease, such as Parkinson's. Acclaimed author Kevin Davies introduces the pioneers of this medical revolution and probes deeply into both the medical benefits and ethical issues of personal genetic testing, also exploring the psychological complexities of learning one's DNA results, based on both his own experience of being tested and that of a number of others. The $1,000 Genome is an indispensable guide to the new era of personalized medicine.… (más)
Ninguno
Cargando...

Inscríbete en LibraryThing para averiguar si este libro te gustará.

Actualmente no hay Conversaciones sobre este libro.

Mostrando 1-5 de 6 (siguiente | mostrar todos)
An excellent intro to the current state of DNA sequencing, the personalities behind some of the leading companies and technologies in the field and the ethical and cultural issues implicated by personal genomics.

DNA sequencing is evolving so quickly that the description of the industry is already a bit out of date. Davies must have started on this in 2007 or earlier.

That said, it would probably be impossible to write a book that wouldn't seem a little dated by the time of publication.
( )
  Robert_Musil | Dec 15, 2019 |
This was a rather boring book. I wouldn't recommend you read it unless you had to. ( )
  meowism | May 17, 2016 |
Good overview of the current state of the art and the surrounding ethical and scientific questions in easy to understand terms. ( )
  ndpmcIntosh | Mar 21, 2016 |
A whirlwind tour of the state of the art in genomic technology circa 2010 by a well informed and well connected author. I found the book well written and a valuable source of information on and insight into a rapidly changing field.

There is information in this book which is difficult to find anywhere else. What is the technology used by Halcycon Molecular? What is the origin of the technology in use at Ion Torrent? What were insiders saying at critical time points about the various technologies?

Not for amateurs? Perhaps. For those with more than a passing interest in developments in personal genomics, however, it is a must read. ( )
  jotter | Jul 27, 2011 |
This book should be titled 'The new companies that want to sequence your genome', because unfortunately that's what it's mostly about. Davies touches on all of the interesting technologies, applications and possible consequences of this 'revolution' that is certainly going to occur, but doesn't try to get grips with any of them.

Topics such as epigenetics and computational biology are mentioned and not explored, when they will both be key to genome sequencing fulfilling it's real potential, whereas the sequencing itself and principles involved are explained but probably not accessible enough for the non-biologist. Therefore there is little to recommend it to either the interested scientist who wants a more in depth discussion, or an interested non-scientist who would need a lot of prior knowledge from other sources if they are really going to gain from this book.

If you are interested in learning the background of the companies and major players in what is sure to be a new biotech industry, then this is the book for you. But if you want to understand the biology or technology or think about the considerable potential consequences then look elsewhere. ( )
1 vota tlickiss | Mar 5, 2011 |
Mostrando 1-5 de 6 (siguiente | mostrar todos)
sin reseñas | añadir una reseña
Debes iniciar sesión para editar los datos de Conocimiento Común.
Para más ayuda, consulta la página de ayuda de Conocimiento Común.
Título canónico
Título original
Títulos alternativos
Fecha de publicación original
Personas/Personajes
Lugares importantes
Acontecimientos importantes
Películas relacionadas
Epígrafe
Dedicatoria
Primeras palabras
Citas
Últimas palabras
Aviso de desambiguación
Editores de la editorial
Blurbistas
Idioma original
DDC/MDS Canónico
LCC canónico

Referencias a esta obra en fuentes externas.

Wikipedia en inglés (3)

Science. Nonfiction. Since the conclusion of the Human Genome Project in 2003, scientists have been racing toward a grand goal: offering individuals a decoding of their complete genetic makeup for just $1,000. As Kevin Davies reveals in this exquisitely reported account, the $1,000 genome will be a reality by 2011 and it will usher in a whole new era of personalized, genomic medicine. Capable of presenting much more advanced information than the current crop of cheek-swab services, the $1,000 complete genome raises some extraordinary possibilities. We will be able to learn if we have genes that predispose us to a host of diseases and to take a wide range of preventative measures. Drug companies may be able to create versions of drugs tailored specifically to our individual DNA. But we may also face the psychological burden of learning that we have the gene for an incurable disease, such as Parkinson's. Acclaimed author Kevin Davies introduces the pioneers of this medical revolution and probes deeply into both the medical benefits and ethical issues of personal genetic testing, also exploring the psychological complexities of learning one's DNA results, based on both his own experience of being tested and that of a number of others. The $1,000 Genome is an indispensable guide to the new era of personalized medicine.

No se han encontrado descripciones de biblioteca.

Descripción del libro
Resumen Haiku

Debates activos

Ninguno

Cubiertas populares

Enlaces rápidos

Valoración

Promedio: (3.21)
0.5
1 1
1.5
2 2
2.5 1
3 3
3.5
4 3
4.5
5 2

¿Eres tú?

Conviértete en un Autor de LibraryThing.

 

Acerca de | Contactar | LibraryThing.com | Privacidad/Condiciones | Ayuda/Preguntas frecuentes | Blog | Tienda | APIs | TinyCat | Bibliotecas heredadas | Primeros reseñadores | Conocimiento común | 206,557,214 libros! | Barra superior: Siempre visible